Inotrem

Adrenomed

This biopharmaceutical company develops monoclonal antibody therapies to restore vascular integrity for critically ill patients suffering from sepsis and septic shock.

Modus Therapeutics

This biotechnology company develops sevuparin to treat patients suffering from sepsis, septic shock, severe malaria and chronic systemic inflammation.

Innate Pharma

This biotechnology company develops antibody-based immunotherapies for cancer and inflammatory diseases for patients with unmet medical needs.

AM Pharma

This biopharmaceutical company develops recombinant human alkaline phosphatase therapeutics to treat patients suffering from sepsis-associated acute kidney injury and other severe inflammatory conditions.

InflaRx

This biopharmaceutical company develops anti-inflammatory inhibitors for hospitals to treat patients with life-threatening autoimmune and inflammatory conditions.

PATH EX, Inc.

This company develops a medical device that removes bacteria and endotoxins from the bloodstream to treat sepsis patients in clinical settings.

Inflammatix

This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.

Evommune

This biotechnology company develops medicinal therapies to treat patients suffering from chronic inflammatory and immune-mediated diseases.